Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000925999 | SCV001071556 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029513 | SCV005029304 | likely benign | Inborn genetic diseases | 2023-12-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001272198 | SCV001453928 | uncertain significance | Dyskeratosis congenita | 2020-02-13 | no assertion criteria provided | clinical testing | |
Genetic Services Laboratory, |
RCV003151222 | SCV003840008 | likely benign | not specified | 2022-09-13 | no assertion criteria provided | clinical testing |